{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:37:12Z","timestamp":1780695432287,"version":"3.54.1"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arbres.2026.01.009","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:12:27Z","timestamp":1769818347000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Respiratory Syncytial Virus in Pediatrics: Update on Epidemiology, Management, Long-term Consequences and Prevention. Consensus From Asociaci\u00f3n Latinoamericana de T\u00f3rax (ALAT) 2025"],"prefix":"10.1016","author":[{"given":"Manuel Enrique","family":"Soto-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranniery","family":"Acu\u00f1a Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Parra-Buitrago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Zepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Castro-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Juarez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Rosal-Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydiana","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10340","key":"10.1016\/j.arbres.2026.01.009_bib0870","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.arbres.2026.01.009_bib0875","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1016\/S2214-109X(17)30344-3","article-title":"Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series","volume":"5","author":"Scheltema","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10.1016\/j.arbres.2026.01.009_bib0880","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S2213-2600(20)30109-0","article-title":"Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis","volume":"8","author":"Brunwasser","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.arbres.2026.01.009_bib0885","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0b013e31829061e8","article-title":"Association between respiratory syncytial virus hospitalizations in infants and respiratory sequelae: systematic review and meta-analysis","volume":"32","author":"R\u00e9gnier","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.arbres.2026.01.009_bib0890","first-page":"34","article-title":"Association of respiratory virus types with clinical features in bronchiolitis: implications for virus testing strategies. A systematic review and meta-analysis","volume":"49","author":"Ambrozej","year":"2024","journal-title":"Paediatr Respir Rev"},{"issue":"10","key":"10.1016\/j.arbres.2026.01.009_bib0895","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1002\/ppul.25582","article-title":"During the COVID-19 pandemic where has respiratory syncytial virus gone?","volume":"56","author":"Di Mattia","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arbres.2026.01.009_bib0900","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.11.05007","article-title":"Absence of detection of RSV and influenza during the COVID-19 pandemic in a Brazilian cohort: likely role of lower transmission in the community","volume":"11","author":"Varela","year":"2021","journal-title":"J Glob Health"},{"issue":"12","key":"10.1016\/j.arbres.2026.01.009_bib0905","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/cid\/ciaa1475","article-title":"Impact of coronavirus disease 2019 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter","volume":"72","author":"Yeoh","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib0910","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/idr14010017","article-title":"The influence of COVID-19 on influenza and respiratory syncytial virus activities","volume":"14","author":"Mondal","year":"2022","journal-title":"Infect Dis Rep"},{"issue":"6","key":"10.1016\/j.arbres.2026.01.009_bib0915","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.15973","article-title":"Trends in respiratory virus infections during the COVID-19 pandemic in Singapore, 2020","volume":"4","author":"Wan","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib0920","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41467-021-21157-9","article-title":"Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand","volume":"12","author":"Huang","year":"2021","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.arbres.2026.01.009_bib0925","doi-asserted-by":"crossref","first-page":"e2829","DOI":"10.1093\/cid\/ciaa1906","article-title":"The interseasonal resurgence of respiratory syncytial virus in australian children following the reduction of coronavirus disease 2019-related public health measures","volume":"73","author":"Foley","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib0930","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s15010-023-02085-w","article-title":"Old foes following news ways? Pandemic-related changes in the epidemiology of viral respiratory tract infections","volume":"52","author":"Maison","year":"2024","journal-title":"Infection"},{"issue":"10303","key":"10.1016\/j.arbres.2026.01.009_bib0935","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(21)01207-1","article-title":"Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019","volume":"398","author":"Collaborators","year":"2021","journal-title":"Lancet"},{"issue":"10200","key":"10.1016\/j.arbres.2026.01.009_bib0940","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(19)30721-4","article-title":"Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case\u2013control study","volume":"394","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib0945","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12887-022-03235-z","article-title":"Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents","volume":"22","author":"Rueda","year":"2022","journal-title":"BMC Pediatr"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib0950","doi-asserted-by":"crossref","DOI":"10.1111\/pai.14083","article-title":"Age-specific predictors of disease severity in children with respiratory syncytial virus infection beyond infancy and through the first 5 years of age","volume":"35","author":"Brenes-Chacon","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"issue":"Suppl. 3","key":"10.1016\/j.arbres.2026.01.009_bib0955","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1093\/infdis\/jit517","article-title":"Respiratory syncytial virus infection in Guatemala, 2007\u20132012","volume":"208","author":"McCracken","year":"2013","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.arbres.2026.01.009_bib0960","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jpids\/piad042","article-title":"Respiratory syncytial virus infection among hospitalized infants in four middle-income countries","volume":"12","author":"Biggs","year":"2023","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib0965","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13056","article-title":"Etiologies of outpatient medically attended acute respiratory infections among young Ecuadorian children prior to the start of the 2020 SARS-CoV-2 pandemic","volume":"17","author":"Suryadevara","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"issue":"10","key":"10.1016\/j.arbres.2026.01.009_bib0970","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1128\/JCM.41.10.4879-4882.2003","article-title":"Surveillance for respiratory syncytial virus in infants hospitalized for acute lower respiratory infection in Chile (1989 to 2000)","volume":"41","author":"Avendano","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.arbres.2026.01.009_bib0975","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1377968","article-title":"Respiratory syncytial virus disease burden in children and adults from Latin America: a systematic review and meta-analysis","volume":"12","author":"Ciapponi","year":"2024","journal-title":"Front Public Health"},{"issue":"6","key":"10.1016\/j.arbres.2026.01.009_bib0980","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/INF.0000000000002271","article-title":"Burden of respiratory syncytial virus disease and mortality risk factors in Argentina: 18 years of active surveillance in a children's hospital","volume":"38","author":"Gentile","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.arbres.2026.01.009_bib0985","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/infdis\/jiaa046","article-title":"Respiratory failure and death in vulnerable premature children with lower respiratory tract illness","volume":"222","author":"Ofman","year":"2020","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.arbres.2026.01.009_bib0990","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1111\/apa.13552","article-title":"Down's syndrome is a risk factor for severe lower respiratory tract infection due to respiratory syncytial virus","volume":"105","author":"Galleguillos","year":"2016","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1016\/j.arbres.2026.01.009_bib0995","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0225","article-title":"Down syndrome and the risk of severe RSV infection: a meta-analysis","volume":"142","author":"Beckhaus","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1000","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13031","article-title":"Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: a systematic literature review and meta-analysis","volume":"17","author":"Savic","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"issue":"6","key":"10.1016\/j.arbres.2026.01.009_bib1005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.37201\/req\/049.2024","article-title":"Impact in the adult population of immunization with nirsevimab in children under 6 months of age against respiratory syncytial virus","volume":"37","author":"Reina","year":"2024","journal-title":"Rev Esp Quimioter."},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1010","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2381298","article-title":"Economic burden of respiratory syncytial virus disease in Latin America: a systematic review","volume":"20","author":"Moreno","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1015","first-page":"462","article-title":"Direct costs of low respiratory infection due to RSV in children under one year","volume":"89","author":"Zepeda","year":"2018","journal-title":"Rev Chil Pediatr"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12889-024-17878-3","article-title":"Cost of illness due to respiratory syncytial virus acute lower respiratory tract infection among infants hospitalized in Argentina","volume":"24","author":"Dvorkin","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2023-001618","article-title":"Pulmonary sequelae in 2-year-old children after hospitalisation for respiratory syncytial virus lower respiratory tract infection during infancy: an observational study","volume":"10","author":"Verwey","year":"2023","journal-title":"BMJ Open Respir Res"},{"issue":"3","key":"10.1016\/j.arbres.2026.01.009_bib1030","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ppul.26810","article-title":"Infants hospitalized with lower respiratory tract infections during the first two years of life have increased risk of pediatric obstructive sleep apnea","volume":"59","author":"Gayoso-Liviac","year":"2024","journal-title":"Pediatr Pulmonol"},{"issue":"10389","key":"10.1016\/j.arbres.2026.01.009_bib1035","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0140-6736(23)00811-5","article-title":"Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study","volume":"401","author":"Rosas-Salazar","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2024-000975","article-title":"Assessing the long-term economic impact of wheezing episodes after severe RSV disease in children from Argentina: a cost of illness analysis","volume":"2","author":"Dvorkin","year":"2024","journal-title":"BMJ Public Health."},{"issue":"11","key":"10.1016\/j.arbres.2026.01.009_bib1045","article-title":"Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children","volume":"11","author":"Garegnani","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S2213-2600(18)30055-9","article-title":"Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial","volume":"6","author":"Scheltema","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2026.01.009_bib1055","first-page":"53","article-title":"The impact of viral bronchiolitis phenotyping: Is it time to consider phenotype-specific responses to individualize pharmacological management?","volume":"34","author":"Rodr\u00edguez-Mart\u00ednez","year":"2020","journal-title":"Paediatr Respir Rev"},{"issue":"12","key":"10.1016\/j.arbres.2026.01.009_bib1060","doi-asserted-by":"crossref","first-page":"zsab198","DOI":"10.1093\/sleep\/zsab198","volume":"44","author":"Gutierrez","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.arbres.2026.01.009_bib1065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1017325","article-title":"Respiratory virus type to guide predictive enrichment approaches in the management of the first episode of bronchiolitis: a systematic review","volume":"13","author":"Ambrozej","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.arbres.2026.01.009_bib1070","article-title":"Characterisation of the respiratory syncytial virus seasonality and its environmental factors in the Americas \u2013 a multi-country observational study using routine surveillance networks","volume":"48","author":"Couto","year":"2025","journal-title":"Lancet Reg Health Am"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1075","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/v13040696","article-title":"Epidemiology and seasonality of childhood respiratory syncytial virus infections in the tropics","volume":"13","author":"Suryadevara","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12889-019-6824-z","article-title":"Factors associated with fatal cases of acute respiratory infection (ARI) among hospitalized patients in Guatemala","volume":"19","author":"Tomczyk","year":"2019","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.arbres.2026.01.009_bib1085","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/cid\/ciz585","article-title":"Assessing the incidence of symptomatic respiratory syncytial virus illness within a prospective birth cohort in Managua, Nicaragua","volume":"70","author":"Kubale","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1090","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/ppul.25866","article-title":"Predictors of poor outcomes of respiratory syncytial virus acute lower respiratory infections in children under 5 years of age in a middle-income tropical country based on the National Public Health Surveillance System","volume":"57","author":"Rodriguez-Martinez","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl_3","key":"10.1016\/j.arbres.2026.01.009_bib1095","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1093\/cid\/ciab497","article-title":"Community mortality due to respiratory syncytial virus in Argentina: population-based surveillance study","volume":"73","author":"Caballero","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1100","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/14760584.2025.2524530","article-title":"Advancing Respiratory Syncytial Virus (RSV) prevention in Latin America: updated recommendations from the Pediatric Infectious Diseases Society of Latin America (SLIPE) expert group on RSV prevention","volume":"24","author":"\u00c1vila-Ag\u00fcero","year":"2025","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1105","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2025.103183","article-title":"Mexican interdisciplinary consensus on the diagnosis and preventive measures for respiratory syncytial virus infections","volume":"56","author":"Wong-Chew","year":"2025","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arbres.2026.01.009_bib1110","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1386082","article-title":"Confronting the challenge: a regional perspective by the Latin American pediatric infectious diseases society (SLIPE) expert group on respiratory syncytial virus-tackling the burden of disease and implementing preventive solutions","volume":"12","author":"Debbag","year":"2024","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1115","first-page":"104","article-title":"Actualizaci\u00f3n en el abordaje y el manejo del paciente con bronquiolitis en Costa Rica","volume":"22","author":"Avila","year":"2010","journal-title":"Acta Paediatr Costarric"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4067\/s0717-73482024000400261","article-title":"Bronquiolitis viral: recomendaciones sobre su manejo en Chile 2024","volume":"40","author":"Zepeda","year":"2024","journal-title":"Rev Chil Enferm Respir"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1125","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2013-2005","article-title":"Bronchiolitis management before and after the AAP guidelines","volume":"133","author":"Parikh","year":"2014","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.emc.2017.12.006","article-title":"Bronchiolitis: from practice guideline to clinical practice","volume":"36","author":"Kou","year":"2018","journal-title":"Emerg Med Clin North Am"},{"issue":"8","key":"10.1016\/j.arbres.2026.01.009_bib1135","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/jpc.70144","article-title":"Australasian bronchiolitis guideline: 2025 update","volume":"61","author":"Borland","year":"2025","journal-title":"J Paediatr Child Health"},{"issue":"6","key":"10.1016\/j.arbres.2026.01.009_bib1140","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"Am J Dis Child"},{"issue":"9178","key":"10.1016\/j.arbres.2026.01.009_bib1145","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.arbres.2026.01.009_bib1150","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1414","article-title":"Infant respiratory syncytial virus infection and childhood asthma: a shift in the paradigm?","volume":"13","author":"Rosas-Salazar","year":"2023","journal-title":"Clin Transl Med"},{"issue":"8","key":"10.1016\/j.arbres.2026.01.009_bib1155","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMc1307429","article-title":"Respiratory syncytial virus and recurrent wheeze","volume":"369","author":"Blanken","year":"2013","journal-title":"N Engl J Med"},{"issue":"Suppl. 7","key":"10.1016\/j.arbres.2026.01.009_bib1160","article-title":"Association between respiratory syncytial virus-associated acute lower respiratory infection in early life and recurrent wheeze and asthma in later childhood","volume":"222","author":"Shi","year":"2020","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.arbres.2026.01.009_bib1165","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0000000000001167","article-title":"The impact of respiratory syncytial virus disease prevention on pediatric asthma","volume":"35","author":"Caballero","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1170","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1542\/peds.2013-0982","article-title":"Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants","volume":"132","author":"Yoshihara","year":"2013","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.arbres.2026.01.009_bib1175","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/thx.2009.121582","article-title":"Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life","volume":"65","author":"Sigurs","year":"2010","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1180","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","article-title":"Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7","volume":"161","author":"Sigurs","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.02.010","article-title":"Determinants of asthma after severe respiratory syncytial virus bronchiolitis","volume":"130","author":"Bacharier","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.02.021","article-title":"The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma","volume":"123","author":"Carroll","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.arbres.2026.01.009_bib1195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.826666","article-title":"Effect of infant RSV infection on memory T cell responses at age 2-3 years","volume":"13","author":"Chirkova","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1200","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.202009-3696OC","article-title":"Recurrent severe preschool wheeze: from prespecified diagnostic labels to underlying endotypes","volume":"204","author":"Robinson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1205","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00199913","article-title":"Classification and pharmacological treatment of preschool wheezing: changes since 2008","volume":"43","author":"Brand","year":"2014","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.arbres.2026.01.009_bib1210","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1164\/rccm.200804-579OC","article-title":"Evidence of a causal role of winter virus infection during infancy in early childhood asthma","volume":"178","author":"Wu","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1164\/rccm.201609-1812OC","article-title":"Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing six-year follow-up study","volume":"196","author":"Mochizuki","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40121-017-0151-4","article-title":"The burden and long-term respiratory morbidity associated with respiratory syncytial virus infection in early childhood","volume":"6","author":"Fauroux","year":"2017","journal-title":"Infect Dis Ther"},{"issue":"3","key":"10.1016\/j.arbres.2026.01.009_bib1225","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13741","article-title":"The role of respiratory syncytial virus- and rhinovirus-induced bronchiolitis in recurrent wheeze and asthma \u2013 a systematic review and meta-analysis","volume":"33","author":"Makrinioti","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125422","article-title":"Long-term burden and respiratory effects of respiratory syncytial virus hospitalization in preterm infants \u2013 the SPRING study","volume":"10","author":"Carbonell-Estrany","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1235","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1185\/03007995.2010.542744","article-title":"Respiratory outcomes, utilization and costs 12 months following a respiratory syncytial virus diagnosis among commercially insured late-preterm infants","volume":"27","author":"Palmer","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1240","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/pai.13134","article-title":"Recurrent wheezing during the first 3 years of life in a birth cohort of moderate-to-late preterm infants","volume":"31","author":"Moreno-Gald\u00f3","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"issue":"19","key":"10.1016\/j.arbres.2026.01.009_bib1245","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1211917","article-title":"Respiratory syncytial virus and recurrent wheeze in healthy preterm infants","volume":"368","author":"Blanken","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ppul.20058","article-title":"Respiratory morbidity 20 years after RSV infection in infancy","volume":"38","author":"Korppi","year":"2004","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","article-title":"Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13","volume":"171","author":"Sigurs","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.01.009_bib1260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2431-5-31","article-title":"Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway","volume":"5","author":"Fjaerli","year":"2005","journal-title":"BMC Pediatr"},{"issue":"6","key":"10.1016\/j.arbres.2026.01.009_bib1265","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/thx.2008.095547","article-title":"School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants","volume":"64","author":"Greenough","year":"2009","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1270","doi-asserted-by":"crossref","first-page":"673","DOI":"10.24953\/turkjped.2021.04.015","article-title":"Cost of illness of RSV infection in a middle-income tropical country","volume":"63","author":"Buendia","year":"2021","journal-title":"Turk J Pediatr"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1275","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046563","article-title":"Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model","volume":"11","author":"Baral","year":"2021","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1280","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/01.inf.0000122604.32137.29","article-title":"Impact of wheezing after respiratory syncytial virus infection on health-related quality of life","volume":"23","author":"Bont","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.arbres.2026.01.009_bib1285","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s12098-023-04613-w","article-title":"Respiratory syncytial virus infection: an update","volume":"90","author":"Soni","year":"2023","journal-title":"Indian J Pediatr"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1290","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/pathogens12020154","article-title":"Prevention and treatment strategies for respiratory syncytial virus (RSV)","volume":"12","author":"Gatt","year":"2023","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1295","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12879-020-05094-4","article-title":"Comparison of clinical features of acute lower respiratory tract infections in infants with RSV\/HRV infection, and incidences of subsequent wheezing or asthma in childhood","volume":"20","author":"Ding","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.arbres.2026.01.009_bib1300","first-page":"156","article-title":"Risk factors and clinical determinants in bronchiolitis of infancy","volume":"21","author":"Atay","year":"2020","journal-title":"Turk Thorac J"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1305","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid2605.190599","article-title":"Effects of air pollution and other environmental exposures on estimates of severe influenza illness, Washington, USA","volume":"26","author":"Somayaji","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.arbres.2026.01.009_bib1310","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1173842","article-title":"Epidemiology and risk factors of respiratory syncytial virus associated acute respiratory tract infection in hospitalized children younger than 5 years from Sri Lanka","volume":"14","author":"Divarathna","year":"2023","journal-title":"Front Microbiol"},{"issue":"10","key":"10.1016\/j.arbres.2026.01.009_bib1315","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1002\/ppul.26583","article-title":"Exposure to outdoor air pollution and risk of hospitalization for bronchiolitis in an urban environment: a 9-year observational study","volume":"58","author":"Dondi","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl. 1","key":"10.1016\/j.arbres.2026.01.009_bib1320","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40121-020-00390-7","article-title":"Socioeconomic impact of RSV hospitalization","volume":"10","author":"Young","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.arbres.2026.01.009_bib1325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40121-020-00387-2","article-title":"Current state of respiratory syncytial virus disease and management","volume":"10","author":"Chatterjee","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"6","key":"10.1016\/j.arbres.2026.01.009_bib1330","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.3390\/ijerph18062815","article-title":"Housing risk factors associated with respiratory disease: a systematic review","volume":"18","author":"Wimalasena","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1335","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/infdis\/jiaa348","article-title":"Detection of respiratory syncytial virus or rhinovirus weeks after hospitalization for bronchiolitis and the risk of recurrent wheezing","volume":"223","author":"Mansbach","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arbres.2026.01.009_bib1340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.880368","article-title":"RSV prevention in all infants: which is the most preferable strategy?","volume":"13","author":"Esposito","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.arbres.2026.01.009_bib1345","doi-asserted-by":"crossref","DOI":"10.1016\/j.earlhumdev.2022.105666","article-title":"New strategies for the prevention of respiratory syncytial virus (RSV)","volume":"174","author":"Messina","year":"2022","journal-title":"Early Hum Dev"},{"issue":"8","key":"10.1016\/j.arbres.2026.01.009_bib1350","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41579-021-00535-6","article-title":"Transmissibility and transmission of respiratory viruses","volume":"19","author":"Leung","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.arbres.2026.01.009_bib1355","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40121-020-00383-6","article-title":"The future of respiratory syncytial virus disease prevention and treatment","volume":"10","author":"Domachowske","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"13","key":"10.1016\/j.arbres.2026.01.009_bib1360","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.2069","article-title":"CDC eases isolation guidance for respiratory viruses","volume":"331","author":"Anderer","year":"2024","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.arbres.2026.01.009_bib1365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252963","article-title":"Impact of social distancing on the spread of common respiratory viruses during the coronavirus disease outbreak","volume":"16","author":"Kim","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1370","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-063955","article-title":"Summer 2023 ACIP update: RSV prevention and updated recommendations on other vaccines","volume":"152","author":"O\u2019Leary","year":"2023","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1375","first-page":"8088","article-title":"Impact of breastfeeding on the incidence and severity of respiratory syncytial virus (RSV)-associated acute lower respiratory infections in infants: a systematic review highlighting the global relevance of primary prevention","volume":"23","author":"Mineva","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"10","key":"10.1016\/j.arbres.2026.01.009_bib1380","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/ppul.27036","article-title":"Impact of breastfeeding on ICU admissions and need for mechanical ventilation in infants younger than 6 months with RSV+bronchiolitis. An observational study","volume":"59","author":"Jim\u00e9nez-Nogueira","year":"2024","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1385","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3345\/kjp.2019.00402","article-title":"Positive association of breastfeeding on respiratory syncytial virus infection in hospitalized infants: a multicenter retrospective study","volume":"63","author":"Jang","year":"2020","journal-title":"Clin Exp Pediatr"},{"issue":"9","key":"10.1016\/j.arbres.2026.01.009_bib1390","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00767-23","article-title":"Prenatal exposure to RSV season influences first-year risk of RSV lower respiratory illness and RSV-specific immune responses assessed at birth","volume":"97","author":"Nenna","year":"2023","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1395","doi-asserted-by":"crossref","first-page":"243","DOI":"10.20344\/amp.20620","article-title":"Strategies to reduce the burden of respiratory syncytial virus infections in children in Portugal: results from the focus group RSV think tank","volume":"37","author":"Ferreira-Magalh\u00e3es","year":"2024","journal-title":"Acta Med Port"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1400","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/v15020280","article-title":"The importance of RSV epidemiological surveillance: a multicenter observational study of RSV infection during the COVID-19 pandemic","volume":"15","author":"Pruccoli","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.arbres.2026.01.009_bib1405","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3389\/fimmu.2020.01507","article-title":"Current insights in the development of efficacious vaccines against RSV","volume":"11","author":"Soto","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1410","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s44197-023-00168-3","article-title":"The impact of non-pharmacological interventions measures against COVID-19 on respiratory virus in preschool children in Henan, China","volume":"14","author":"Yan","year":"2024","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.arbres.2026.01.009_bib1415","series-title":"The health consequences of smoking-50 years of progress: a report of the surgeon general. Reports of the surgeon general. Atlanta (GA)","year":"2014"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1420","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1378\/chest.15-1858","article-title":"Impact of tobacco smoke and nicotine exposure on lung development","volume":"149","author":"Gibbs","year":"2016","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.arbres.2026.01.009_bib1425","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1016\/S2468-2667(21)00097-9","article-title":"Effect of smoke-free policies in outdoor areas and private places on children's tobacco smoke exposure and respiratory health: a systematic review and meta-analysis","volume":"6","author":"Rado","year":"2021","journal-title":"Lancet Public Health"},{"issue":"40","key":"10.1016\/j.arbres.2026.01.009_bib1430","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e311","article-title":"Impact of nonpharmacological interventions on severe acute respiratory infections in children: from the national surveillance database","volume":"38","author":"Yoon","year":"2023","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.arbres.2026.01.009_bib1435","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11739-022-02932-y","article-title":"Emerging evidence for non-pharmacologic interventions in reducing the burden of respiratory illnesses","volume":"17","author":"Khanolkar","year":"2022","journal-title":"Intern Emerg Med"},{"issue":"12","key":"10.1016\/j.arbres.2026.01.009_bib1440","article-title":"COVID-19 lesson for respiratory syncytial virus (RSV): hygiene works","volume":"8","author":"Gastaldi","year":"2021","journal-title":"Children (Basel)"},{"issue":"6","key":"10.1016\/j.arbres.2026.01.009_bib1445","article-title":"Social distancing lockdown and the wide use of mask; a magic solution or a double-edged sword for respiratory viruses epidemiology?","volume":"9","author":"Sanz-Munoz","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"21","key":"10.1016\/j.arbres.2026.01.009_bib1450","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e172","article-title":"Effects of non-pharmacological interventions on respiratory viruses other than SARS-CoV-2: analysis of laboratory surveillance and literature review from 2018 to 2021","volume":"37","author":"Shi","year":"2022","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1455","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/aihb.aihb_36_21","article-title":"COVID-19 pandemic: non-pharmaceutical interventions and addressing polypharmacy for better clinical outcome","volume":"11","author":"Oh","year":"2021","journal-title":"Adv Human Biol"},{"issue":"9","key":"10.1016\/j.arbres.2026.01.009_bib1460","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/ppul.25570","article-title":"Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil","volume":"56","author":"Friedrich","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"32","key":"10.1016\/j.arbres.2026.01.009_bib1465","doi-asserted-by":"crossref","first-page":"508","DOI":"10.15585\/mmwr.mm7432a3","article-title":"Use of clesrovimab for prevention of severe respiratory syncytial virus-associated lower respiratory tract infections in infants: recommendations of the advisory committee on immunization practices \u2013 United States, 2025","volume":"74","author":"Moulia","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"13","key":"10.1016\/j.arbres.2026.01.009_bib1470","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2502984","article-title":"Clesrovimab for prevention of RSV disease in healthy infants","volume":"393","author":"Zar","year":"2025","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1475","article-title":"Recommendations for the prevention of RSV disease in infants and children: policy statement","volume":"156","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.arbres.2026.01.009_bib1480","series-title":"Summary of product characteristics: Arexvy","author":"EMA","year":"2024"},{"key":"10.1016\/j.arbres.2026.01.009_bib1485","first-page":"83","article-title":"Structure and function of respiratory syncytial virus surface glycoproteins","volume":"372","author":"McLellan","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6158","key":"10.1016\/j.arbres.2026.01.009_bib1490","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14776\/piv.2023.30.e2","article-title":"Recent advances in the prevention of RSV in neonates and young infants","volume":"30","author":"Yun","year":"2023","journal-title":"Pediatr Infect Vaccine"},{"issue":"3","key":"10.1016\/j.arbres.2026.01.009_bib1500","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1505","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants, young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","year":"2014","journal-title":"Pediatrics"},{"issue":"166","key":"10.1016\/j.arbres.2026.01.009_bib1510","doi-asserted-by":"crossref","first-page":"220105","DOI":"10.1183\/16000617.0105-2022","article-title":"Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries","volume":"31","author":"Nguyen-Van-Tam","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"7","key":"10.1016\/j.arbres.2026.01.009_bib1515","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/infdis\/jiaa034","article-title":"Premature infants with respiratory syncytial virus (RSV): the need for both maternal and pediatric RSV prevention strategies","volume":"222","author":"Nicholson","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.arbres.2026.01.009_bib1520","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1542\/peds.2014-1666","volume":"134","year":"2014","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1525","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1526-0542(02)00306-8","article-title":"Current strategies in the prevention of respiratory syncytial virus disease","volume":"4","author":"Paes","year":"2003","journal-title":"Paediatr Respir Rev"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1530","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0039-1681014","article-title":"SENTINEL1: two-season study of respiratory syncytial virus hospitalizations among U.S. infants born at 29 to 35 weeks\u2019 gestational age not receiving immunoprophylaxis","volume":"37","author":"Anderson","year":"2020","journal-title":"Am J Perinatol"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1535","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jped.2016.11.006","article-title":"One-year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America","volume":"93","author":"Castillo","year":"2017","journal-title":"J Pediatr (Rio J)"},{"issue":"11","key":"10.1016\/j.arbres.2026.01.009_bib1540","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3855\/jidc.12561","article-title":"Effectiveness of palivizumab immunoprophylaxis in infants with respiratory syncytial virus disease in Colombia","volume":"15","author":"Pineros","year":"2021","journal-title":"J Infect Dev Ctries"},{"issue":"10","key":"10.1016\/j.arbres.2026.01.009_bib1545","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/ppul.26051","article-title":"Impact of immunoprophylaxis with palivizumab on respiratory syncytial virus infection in preterm infants less than 35 weeks in Colombian hospitals","volume":"57","author":"Galvis","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1550","doi-asserted-by":"crossref","first-page":"355","DOI":"10.15537\/smj.2021.42.4.20200769","article-title":"Saudi experts\u2019 recommendation for RSV prophylaxis in the era of COVID-19: consensus from the Saudi Pediatric Pulmonology Association","volume":"42","author":"Alharbi","year":"2021","journal-title":"Saudi Med J"},{"issue":"7\u20138","key":"10.1016\/j.arbres.2026.01.009_bib1555","doi-asserted-by":"crossref","first-page":"363","DOI":"10.14745\/ccdr.v48i78a08","article-title":"Summary of the National Advisory Committee on Immunization (NACI) statement update on the recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants","volume":"48","author":"Moore","year":"2022","journal-title":"Can Commun Dis Rep"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1560","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ppul.23960","article-title":"Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants","volume":"53","author":"Blanken","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arbres.2026.01.009_bib1565","first-page":"35","article-title":"Expert consensus on palivizumab use for respiratory syncytial virus in developed countries","volume":"33","author":"Luna","year":"2020","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1570","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/INF.0000000000000918","article-title":"Respiratory syncytial virus preterm (32\u201336 completed weeks of gestation) risk estimation measure for RSV hospitalization in Ireland: a prospective study","volume":"35","author":"Sheridan-Pereira","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1575","doi-asserted-by":"crossref","first-page":"2023061803","DOI":"10.1542\/peds.2023-061803","article-title":"Palivizumab prophylaxis in infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"152","author":"Caserta","year":"2023","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1580","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.arbres.2026.01.009_bib1585","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2214773","article-title":"Nirsevimab for prevention of RSV in term and late-preterm infants","volume":"388","author":"Muller","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.arbres.2026.01.009_bib1590","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.arbres.2026.01.009_bib1595","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","article-title":"Nirsevimab for prevention of hospitalizations due to RSV in infants","volume":"389","author":"Drysdale","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.arbres.2026.01.009_bib1600","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/jpids\/piad052","article-title":"Safety of re-dosing nirsevimab prior to RSV season 2 in children with heart or lung disease","volume":"12","author":"Domachowske","year":"2023","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1605","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2348135","article-title":"Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol","volume":"20","author":"Mallah","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.arbres.2026.01.009_bib1610","series-title":"Campa\u00f1a de invierno: autoridades de salud informan al presidente Boric positivo impacto de la inmunizaci\u00f3n con nirsevimab","year":"2024"},{"key":"10.1016\/j.arbres.2026.01.009_bib1615","series-title":"En un 87.6% se ha reducido la tasa de hospitalizaci\u00f3n en menores de un a\u00f1o en relaci\u00f3n con el 2023 en igual per\u00edodo","year":"2024"},{"key":"10.1016\/j.arbres.2026.01.009_bib1620","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1641085","article-title":"Nirsevimab for preventing respiratory syncytial virus lower respiratory tract infections in infants: a systematic review and meta-analysis","volume":"13","author":"Soudani","year":"2025","journal-title":"Front Public Health"},{"issue":"11","key":"10.1016\/j.arbres.2026.01.009_bib1625","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1473-3099(25)00233-6","article-title":"Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study","volume":"25","author":"Torres","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.arbres.2026.01.009_bib1630","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102680","article-title":"Cost-savings and health impact of strategies for prevention of Respiratory Syncytial Virus with nirsevimab in Chile based on the integrated analysis of 2019\u20132023 national databases: a retrospective study","volume":"18","author":"Saur\u00e9","year":"2025","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1635","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/14760584.2025.2562201","article-title":"Cost-effectiveness of strategies using preventive interventions to protect infants in Chile from respiratory syncytial virus","volume":"24","author":"Bolanos","year":"2025","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1640","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/ppul.26920","article-title":"Exploratory analysis of the economically justifiable price of nirsevimab for healthy late-preterm and term infants in Colombia","volume":"59","author":"Buendia","year":"2024","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.arbres.2026.01.009_bib1645","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12137-1","article-title":"A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein","volume":"10","author":"Tang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.arbres.2026.01.009_bib1650","series-title":"Package Insert \u2013 AREXVY","year":"2024"},{"issue":"11","key":"10.1016\/j.arbres.2026.01.009_bib1655","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix503","article-title":"An adjuvanted postfusion F protein-based vaccine did not prevent respiratory syncytial virus illness in older adults","volume":"216","author":"Falloon","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arbres.2026.01.009_bib1660","series-title":"First RSV vaccine to protect infants up to 6 months of age and older adults 2023","author":"Em","year":"2023"},{"issue":"17","key":"10.1016\/j.arbres.2026.01.009_bib1665","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMoa2106062","article-title":"Prefusion F protein-based respiratory syncytial virus immunization in pregnancy","volume":"386","author":"Sim\u00f5es","year":"2022","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.arbres.2026.01.009_bib1670","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.arbres.2026.01.009_bib1675","doi-asserted-by":"crossref","first-page":"126041","DOI":"10.1016\/j.vaccine.2024.06.009","article-title":"Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trial","volume":"42","author":"Otsuki","year":"2024","journal-title":"Vaccine."},{"key":"10.1016\/j.arbres.2026.01.009_bib1680","series-title":"ACIP presentation slides: June 26\u201328, 2024 meeting: respiratory syncytial virus vaccines \u2013 adult","year":"2024"},{"issue":"7","key":"10.1016\/j.arbres.2026.01.009_bib1685","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.19268","article-title":"Nonadjuvanted bivalent respiratory syncytial virus vaccination and perinatal outcomes","volume":"7","author":"Son","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.arbres.2026.01.009_bib1690","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.19229","article-title":"Perinatal outcomes after RSV vaccination during pregnancy-addressing emerging concerns","volume":"7","author":"Regan","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"41","key":"10.1016\/j.arbres.2026.01.009_bib1695","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","volume":"72","author":"Fleming-Dutra","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.arbres.2026.01.009_bib1700","series-title":"PAHO Technical Advisory Group (TAG) on immunization provides regional recommendations on vaccines against dengue, respiratory syncytial virus, and issues statement on ongoing use of COVID-19 vaccines","year":"2024"},{"key":"10.1016\/j.arbres.2026.01.009_bib1705","unstructured":"Legislaci\u00f3n y Avisos Oficiales \u2013 Resoluci\u00f3n 4218\/2023 (2023)."},{"key":"10.1016\/j.arbres.2026.01.009_bib1710","unstructured":"Acta P\u00fablica Reuni\u00f3n Comisi\u00f3n Nacional Asesora de Inmunizaciones (CNAV) (2024)."},{"key":"10.1016\/j.arbres.2026.01.009_bib1715","unstructured":"Acta Publica \u2013 Reunion Comisi\u00f3n Nacional Asesora de Inmunizaciones (CNAV) \u2013 Vacunaci\u00f3n virus respiratorio sincitial (VRS) (2024)."},{"issue":"2s","key":"10.1016\/j.arbres.2026.01.009_bib1720","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/INF.0000000000004693","article-title":"Identifying gaps and opportunities for maternal and neonatal immunization research and implementation in Latin America","volume":"44","author":"S\u00e1fadi","year":"2025","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.arbres.2026.01.009_bib1725","doi-asserted-by":"crossref","DOI":"10.1016\/j.jped.2025.101445","article-title":"Strengthening RSV prevention in early life through new generation strategies","volume":"101","author":"Mejias","year":"2025","journal-title":"J Pediatr (Rio J)"},{"issue":"Suppl. 1","key":"10.1016\/j.arbres.2026.01.009_bib1730","first-page":"S120","article-title":"New advances in RSV: is prevention attainable?","volume":"60","author":"Zar","year":"2025","journal-title":"Pediatr Pulmonol"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T02:50:14Z","timestamp":1771987814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289626000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":173,"alternative-id":["S0300289626000372"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2026.01.009","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory Syncytial Virus in Pediatrics: Update on Epidemiology, Management, Long-term Consequences and Prevention. Consensus From Asociaci\u00f3n Latinoamericana de T\u00f3rax (ALAT) 2025","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2026.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEPAR.","name":"copyright","label":"Copyright"}]}}